Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2)

This study has been terminated.

( poor patient recrutment )

Study NCT00120796 Information provided by French National Agency for Research on AIDS and Viral Hepatitis

First Received: July 12, 2005 Last Updated: March 28, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	July 2008
Estimated Primary Completion Date:	July 2008 (Final data collection date for primary outcome measure)